79376665 - SPHERE FLUIDICS

Information

• Trademark
• 79376665

• Source

• Serial Number

  79376665

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 11, 2023
  2 years ago

• Transaction Date

  June 10, 2025
  4 months ago

• Status Date

  June 10, 2025
  4 months ago

• Published for Opposition Date

  June 10, 2025
  4 months ago

• Location Date

  May 19, 2025
  5 months ago

• Status Code

  686

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ALLEN, BIANCA

• Attorney Docket Number

  MCUK-70528

  Attorney Name

  MICHELLE E. TOCHTROP

  Law Office Assigned Location Code

  N50

• Owners

  • SPHERE FLUIDICS LIMITED

Case File Statements

• DM0000: The mark consists of the stylized stacked wording "SPHERE FLUIDICS", with a stylized upside down teardrop shape to the right of the word "SPHERE".
• GS0091: Laboratory apparatus and instruments, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; Laboratory apparatus and instruments, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; Laboratory apparatus and instruments, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for use in cell detection and molecular discovery, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; laboratory apparatus and instruments for use in cell detection and molecular discovery, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for use in cell detection and molecular discovery, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis, retrieval and discovery of single cells, genes, or populations of proteins and molecules, contained in individual pico droplets, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; laboratory apparatus and instruments for the analysis, retrieval and discovery of single cells, genes, or populations of proteins and molecules, contained in individual pico droplets, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis, retrieval and discovery of single cells, genes, or populations of proteins and molecules, contained in individual pico droplets, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis of biomarkers, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; laboratory apparatus and instruments for the analysis of biomarkers, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis of biomarkers, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; replacement parts and fittings in the nature of reflective mirrors for scientific use, tubing for scientific use, fluidic components namely, flow cells, controlled volume pumps and control valves for regulating the flow of gases and liquids, optical components namely, lasers for non-medical purposes, and light detectors, and electronic components namely, circuit boards, power supplies and electronic data processing apparatus for all the aforesaid goods
• GS0051: Chemical preparations for medical purposes, namely, preparations for the treatment of cancer, cardiovascular, immunological, central nervous system, and metabolic diseases, genetic diseases, microbial infections, viral infections
• GS0011: Chemicals for use in industry and science; chemical reagents, other than for medical or veterinary purposes; chemical solutions, namely, gas soluble oils containing a surfactant, azo-dye, and biological reagents; surfactants for use in drug discovery and development, medical diagnostic applications, genetic research, synthetic biology and life sciences research namely, fluorinated or non-fluorinated surfactants, biocompatible surfactants, emulsifiers, dispersants, wetting agents; chemical coating agents for use in improving or enabling microfluidic processes namely, surfactants, polymers and other coating agents for enhancing fluid flow and controlling surface wettability in microfluidic devices and systems; chemical agents for de-emulsifying solutions, namely, demulsifiers, destabilizers, and phase-separating compounds, proteins and enzymes for breaking down emlusions; unprocessed polymers; pico droplets and microfluids for use in cell detection and molecular discovery being microscale fluid compartments encapsulated in an immiscible carrier fluid or microscale fluid compartments surrounding by an immiscible fluid shell in an immiscible carrier fluid for use in cell detection and molecular discovery, other than for medical or veterinary purposes
• DS0000: "FLUIDICS"
• GS0421: Scientific research and development; biopharmaceutical discovery being drug discovery and biopharmaceutical drug development; cell therapy engineering; scientific research and development, namely, bioproduction and synthetic biology, analysis and isolation

Case File Event Statements

• 8/17/2023 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 8/18/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/22/2023 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 10/15/2023 - 2 years ago

  4 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV

• 1/17/2024 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 1/19/2024 - a year ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/20/2024 - a year ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/6/2024 - a year ago

  8 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR

• 2/9/2024 - a year ago

  9 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/10/2024 - a year ago

  10 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/27/2024 - a year ago

  11 - CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Type: CREV

• 3/4/2024 - a year ago

  12 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/4/2024 - a year ago

  13 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/4/2024 - a year ago

  14 - ATTORNEY REVIEW COMPLETED Type: ATRV

• 3/27/2024 - a year ago

  15 - REFUSAL PROCESSED BY IB Type: RFNT

• 9/4/2024 - a year ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/4/2024 - a year ago

  16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/4/2024 - a year ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/30/2024 - a year ago

  20 - FINAL REFUSAL E-MAILED Type: GNFR

• 9/30/2024 - a year ago

  21 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 9/30/2024 - a year ago

  19 - FINAL REFUSAL WRITTEN Type: CNFR

• 1/28/2025 - 8 months ago

  24 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/28/2025 - 8 months ago

  26 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 1/28/2025 - 8 months ago

  23 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 1/28/2025 - 8 months ago

  22 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 1/28/2025 - 8 months ago

  27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/28/2025 - 8 months ago

  25 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/11/2025 - 7 months ago

  29 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/18/2025 - 7 months ago

  31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/18/2025 - 7 months ago

  30 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 3/18/2025 - 7 months ago

  32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/29/2025 - 6 months ago

  33 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 3/11/2025 - 7 months ago

  28 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 4/21/2025 - 5 months ago

  36 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1

• 4/21/2025 - 5 months ago

  34 - ACTION CONTINUING A FINAL - COMPLETED Type: CNCF

• 5/6/2025 - 5 months ago

  38 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/6/2025 - 5 months ago

  37 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/6/2025 - 5 months ago

  39 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/6/2025 - 5 months ago

  40 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/6/2025 - 5 months ago

  41 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/4/2025 - 4 months ago

  42 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/10/2025 - 4 months ago

  43 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/10/2025 - 4 months ago

  44 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/21/2025 - 5 months ago

  35 - CONTINUATION OF FINAL REFUSAL E-MAILED Type: GNCF